Synlogic, Inc. (SYBX) |
| 1.22 0.07 (6.09%) 09-10 16:00 |
| Open: | 1.19 |
| High: | 1.23 |
| Low: | 1.19 |
| Volume: | 38,270 |
| Market Cap: | 14(M) |
| PE Ratio: | -20.33 |
| Exchange: | Other OTC |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.45 |
| Resistance 1: | 1.24 |
| Pivot price: | 1.20 |
| Support 1: | 1.17 |
| Support 2: | 1.13 |
| 52w High: | 1.87 |
| 52w Low: | 0.54 |
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Financials
| EPS | -0.050 |
| Book Value | 1.030 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -17.0 |
| Return on Equity (ttm) | -5.3 |
Company news
Sat, 29 Aug 2026
$HAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of the Merger - BWMN, SUNS, DV and SYBX - Morningstar
Fri, 28 Aug 2026
Synlogic Inc. (SYBX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Fri, 28 Aug 2026
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Varex Imaging Corporation (Nasdaq – VREX), Synlogic, Inc. (OTC – SYBX), Bowman Consulting Group Ltd. (Nasdaq – BWMN), Nathan’s Famous, Inc. (Nasda - Procurement Magazine
Fri, 14 Aug 2026
Synlogic (SYBX) investor reprices 2.64M-share warrant from $3.408 to $0.70 - Stock Titan
Mon, 10 Aug 2026
SYBX Stock Alert: Halper Sadeh LLC is Investigating Whether Synlogic, Inc. is Obtaining a Fair Price for its Shareholders - WBOC TV
Wed, 29 Jul 2026
Caldera merges with Synlogic to fund Phase II trials of TL1A × IL-23p19 bispecific for IBD - AllSci
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
